Remdesivir representative image

Photo: The Economic Times

Oral Dose Of Remdesivir To Soon Hit Markets: Research

Gilead Sciences, the developers of Remdesivir, promising treatment against Covid-19, created a modified version of the medicine. The company, as per reports, has partnered with researchers at Georgia State University, where they have found the medicine to be highly effective in surpassing SARS-CoV-2 replication and transmission in animals when given orally. "It would be groundbreaking in improving patient access to treatment early after… read-more

Tue, 09 Nov 2021 - 09:24 PM / by SAM RAHUL RAJASHEKHAR

Tags: covid 19, Noval corona virus, SARs-CoV-2 virus, Georgia university, REMDESIVIR

Courtesy: The Indian Express

Lady and a child tensed during the covid restriction in the city

Photo: BBC

Beijing Records 9 New Covid-19 Cases; China Tightens Restrictions

China reported a rise in the COVID-19 cases with nine new infections in the national capital, Beijing. The government has taken measures to contain the spread of Coronavirus in the city as a high-level gathering of the communist party has been scheduled next week. Moreover, temperature screening machines have been set up all around the public places, tightening restrictions around the country.

Wed, 03 Nov 2021 - 09:52 AM / by SAM RAHUL RAJASHEKHAR

Tags: covid 19, China, Coronavirus Pandemic, Noval corona virus, beijing

Courtesy: Reuters

Corona effect on children

Photo: Time Magazine

43% Children Likely To Have Antibodies To Fight With Corona As Compared To Adults

According to a study led by George Kassiotis, Chief of Retroviral Immunology Laboratory, Francis Crick Institute, researchers have found that immune responses to coronavirus varies in children as compared to adults. Samples from 300 adults and 48 children were compared with 170 people already infected with coronavirus, showed that the antibodies that develops… read-more

Tue, 17 Nov 2020 - 11:54 AM / by Richa Nigam

Tags: health care, Covid-19, Noval corona virus, Health Ministry

Courtesy: Hindustan Times